News tagged with sloan kettering cancer center
Regular physical activity linked to better quality of life in early-stage lung cancer survivors
Feb 03, 2009 |
not rated yet |
0
Survivors of early-stage lung cancer who take part in regular physical activity have a better quality of life, according to a study in the February issue of the journal Cancer Epidemiology Biomarkers and Prevention, available ...
Treatment may need to be modified for elderly brain cancer patients
Jan 13, 2009 |
4 / 5 (2) |
0
Glioblastoma, the most common and aggressive type of brain tumor, accounts for a majority of the brain tumors seen in patients 65 years or older. This segment of the population is growing faster than any other age group and ...
Research shows cell's inactive state is critical for effectiveness of cancer treatment
Biology /
Jan 09, 2009 |
5 / 5 (1) |
0
A new study sheds light on a little understood biological process called quiescence, which enables blood-forming stem cells to exist in a dormant or inactive state in which they are not growing or dividing. According to the ...
Search results for sloan kettering cancer center
New understanding of how to prevent destruction of a tumor suppressor
6 hours ago |
not rated yet |
0
Researchers from the Indiana University School of Medicine and colleagues at the University of Texas Southwestern and Case Western University have determined how the protein Mdm2, which is elevated in late-stage ...
Second-line CML drugs evoke faster response than front-line therapy
6 hours ago |
not rated yet |
0
Two medications approved as treatment for drug-resistant chronic myeloid leukemia continue to provide patients with quicker, better responses as a first treatment than the existing front-line drug, researchers at The University ...
New screening tool helps identify children at risk
9 hours ago |
4 / 5 (1) |
0
When a baby is born, new parents often wonder, "Will he be the next President of the United States?" or "Could she be the one to find a cure for cancer?" But the underlying question for many specialists is, "Is this child ...
Drug shows promise for T315I-mutated chronic myeloid leukemia
10 hours ago |
not rated yet |
0
Results from a phase II clinical trial indicate a novel drug may provide a treatment option for chronic myeloid leukemia (CML) patients who do not respond to current therapies, researchers from The University of Texas M. ...
JAK2 inhibitor demonstrates effective, durable control of myelofibrosis
10 hours ago |
not rated yet |
0
A first-in-its class oral medication provides significant and durable relief for patients with a rare, debilitating and lethal bone marrow disorder called myelofibrosis, researchers at The University of Texas M. D. Anderson ...
Drug shows positive responses, low side-effects in multiple myeloma
11 hours ago |
not rated yet |
0
NEW ORLEANS ― The second-generation proteasome inhibitor carfilzomib is showing noteworthy response rates and low levels of adverse side effects among multiple myeloma patients in a phase II clinical trial, researchers ...
Tiny RNA has big impact on lung cancer tumors
13 hours ago |
5 / 5 (2) |
0
Researchers from Yale University and Mirna Therapeutics, Inc., reversed the growth of lung tumors in mice using a naturally occurring tumor suppressor microRNA. The study reveals that a tiny bit of RNA may one day play a ...
Multiple myeloma patients experience high response rate with new 3-drug combination
Dec 06, 2009 |
not rated yet |
0
A new three-drug combination has shown in a phase 1/2 clinical trial that it is a "highly effective regimen" in the treatment of patients newly diagnosed with multiple myeloma, a cancer of white blood cells in bone marrow, ...
Childhood cancer survivor study report: Late recurrence is a risk for some cancers
Dec 04, 2009 |
not rated yet |
0
Late recurrence is a risk for some pediatric cancers, particularly Ewing sarcomas and tumors of the central nervous system, according to a new study published online December 4 in the Journal of the National Cancer Institute.
Cholesterol-lowering drugs also may protect stem cell transplant patients from GVHD
Dec 04, 2009 |
5 / 5 (1) |
0
Cholesterol-lowering drugs known as statins are among the most prescribed medicines in the U.S. Now a new study by researchers at Fred Hutchinson Cancer Research Center indicates that statins may protect stem cell transplant ...
List of search results for sloan kettering cancer center
